Generation of OCIAD2 homozygous knockout (BJNhem20-OCIAD2-CRISPR-33) and heterozygous knockout (BJNhem20-OCIAD2-CRISPR-40) human embryonic stem cell lines using CRISPR-Cas9 mediated targeting
OCIAD proteins interact with each other. Misexpression of OCIAD2 is implicated in several cancers and
neurodegenerative disorders (Praveen et al., 2020). Hence, OCIAD2 mutant hESC lines will
help in elucidating the role of OCIAD2 in development and disease contexts and will also be useful for studying
OCIAD1.
Generation and characterization of OCIAD2 CRISPR KO hESC lines, BJNhem20-OCIAD2-CRISPR-33 and BJNhem20-OCIAD2-CRISPR-40